GlassScriptPhysician profile
Alberto Marante
NPI 1700931417
$464.69
in general payments reported to CMS, 2019-2025
10 companies · $231 in 2025
The $231 reported for 2025 was more than what 78% of Pediatric Critical Care Medicine providers received nationally (typical 2025 total: $71.68).
See the full distribution for Pediatric Critical Care Medicine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $17.63 · 2024: $216 · 2025: $231.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $465.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $464.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biocryst US Sales Co., LLC | $145.74 | 2024-2025 | Orladeyo |
| Cranial Technologies, INC | $74.56 | 2024-2025 | Doc Band |
| Glaxosmithkline, LLC. | $61.18 | 2023-2024 | Bexsero, Pediarix |
| Pfizer INC. | $44.32 | 2024-2025 | |
| Seqirus USA INC | $37.43 | 2024-2025 | Flucelvax |
| Genentech USA, INC. | $25.08 | 2024 | Xolair |
| Tandem Diabetes Care, INC. | $23.57 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Rhythm Pharmaceuticals, INC. | $20.71 | 2025 | Imcivree |
| Merck Sharp & Dohme LLC | $18.04 | 2025 | Vaxelis, Vaxneuvance |
| Corium, LLC | $14.06 | 2024 | Azstarys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alberto Marante listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.